---
document_datetime: 2025-01-06 14:54:23
document_pages: 18
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nevanac-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: nevanac-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 9.3417283
conversion_datetime: 2025-12-27 20:38:44.484197
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Nevanac

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                 | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IAIN/0059/G          | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - | 18/12/2024                          |                                             | Annex II and PL                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | Not including batch control/testing A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     |           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| IB/0058/G | This was an application for a group of variations. A.z - Administrative change - Other variation B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation B.II.e.1.b.3 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Deletion of an immediate packaging container without a complete deletion of a strength or pharmaceutical form B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information B.II.e.6.z - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Other variation B.II.z - Quality change - Finished product - Other | 27/09/2024 | n/a | variation |

<div style=\"page-break-after: always\"></div>

| IA/0057/G   | was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 27/06/2024   | n/a   | This   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|--------|
| IB/0056/G   | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test | 23/05/2024   | n/a   |        |

<div style=\"page-break-after: always\"></div>

|           | procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.z - Quality change - Finished product - Other variation   |            |            |                       |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|
| IAIN/0055 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                    | 28/02/2024 | 18/11/2024 | SmPC, Annex II and PL |
| IB/0054/G | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                          | 11/11/2023 | 18/11/2024 | SmPC and PL           |

<div style=\"page-break-after: always\"></div>

| PSUSA/2143/ 202205   | Periodic Safety Update EU Single assessment - nepafenac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 12/01/2023   | n/a        |                                  | PRAC Recommendation - maintenance   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-------------------------------------|
| IB/0052/G            | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products | 14/02/2022   | n/a        |                                  |                                     |
| IB/0051              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 18/10/2021   | 14/10/2022 | SmPC, Annex II, Labelling and PL |                                     |
| IA/0050              | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                                                                                                                                                                                                     | 01/02/2021   | n/a        |                                  |                                     |
| IA/0049/G            | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS -                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 07/01/2021   | n/a        |                                  |                                     |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|             | Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a   |            |     |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IAIN/0048/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 26/06/2020 | n/a |

<div style=\"page-break-after: always\"></div>

|           | site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                      |            |     | manufacturing site   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------|
| IB/0047   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 28/05/2020 | n/a |                      |
| IB/0046/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF | 21/02/2020 | n/a |                      |

<div style=\"page-break-after: always\"></div>

|                    | B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.c.2.b - Change in the specification parameters and/or limits of the immediate packaging of the AS - Addition of a new specification parameter to the specification with its corresponding test method   |            |     |                                   |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/2143/ 201905 | Periodic Safety Update EU Single assessment - nepafenac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 16/01/2020 | n/a | PRAC Recommendation - maintenance |
| IB/0045            | B.II.a.3.z - Changes in the composition (excipients) of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 16/10/2019 | n/a |                                   |
| IB/0043            | B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 04/10/2019 | n/a |                                   |
| IB/0044            | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                  | 16/09/2019 | n/a |                                   |
| IA/0041/G          | This was an application for a group of variations. B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                                                                                                                                                                                                                                                                                                                          | 17/05/2019 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|           | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier   |            |     |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0040/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF                                                                                                                                                                                                                                                                                                                 | 05/02/2019 | n/a |

<div style=\"page-break-after: always\"></div>

|           | in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.c.2.b - Change in the specification parameters and/or limits of the immediate packaging of the AS - Addition of a new specification parameter to the specification with its corresponding test method   |            |            |                                  | B.I.a.2.e - Changes   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------|
| IA/0039/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.II.c.4.a - Change in synthesis or recovery of a non- or novel excipient - Minor change                                                                                                                                                                                                                                                                        | 29/11/2018 | n/a        |                                  | pharmacopoeial        |
| IA/0038   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/08/2018 | 26/08/2019 | SmPC, Annex II, Labelling and PL |                       |
| IB/0037   | A.5.b - Administrative change - Change in the name                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 08/08/2018 | n/a        |                                  |                       |

<div style=\"page-break-after: always\"></div>

|                    | and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |                                  |                                                                      |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------|
| T/0036             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 20/03/2018 | 23/04/2018 | SmPC, Labelling and PL           |                                                                      |
| T/0035             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 04/04/2017 | 16/05/2017 | SmPC, Labelling and PL           |                                                                      |
| PSUSA/2143/ 201605 | Periodic Safety Update EU Single assessment - nepafenac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 12/01/2017 | n/a        |                                  | PRAC Recommendation - maintenance                                    |
| II/0033            | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 10/11/2016 | n/a        |                                  |                                                                      |
| II/0032            | Extension of indication to include the indication 'reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients' also for the 3 mg/ml strength based on data from the phase III studies C-12-067 and C-12- 071. As a consequence, sections 4.1, 4.2, 4.4, 4.8, 5.1 and 5.2 of the SmPC have been updated and the Package Leaflet has been updated accordingly. In addition, the MAH took the opportunity to implement editorial changes in SmPC and to update the annexes in line with the latest QRD template. An updated RMP version 8 was agreed during the procedure. | 23/06/2016 | 29/07/2016 | SmPC, Annex II, Labelling and PL | Please refer to the scientific discussion 'Nevanac H-818-II- 32-AR'. |

<div style=\"page-break-after: always\"></div>

|                    | Addition of a new therapeutic indication or modification of an approved one                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |            |                        |                                                                                                                                                    |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2143/ 201505 | Periodic Safety Update EU Single assessment - nepafenac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 14/01/2016 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                  |
| IB/0030/G          | This was an application for a group of variations. B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.c.1.z - Change in the specification parameters and/or limits of an excipient - Other variation B.II.c.4.z - Change in synthesis or recovery of a non- pharmacopoeial or novel excipient - Other variation                                                                                                                                                                                       | 03/07/2015 | n/a        |                        |                                                                                                                                                    |
| PSUV/0029          | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 22/01/2015 | 31/03/2015 | SmPC and PL            | Please refer to Nevanac PSUV-0029 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation. |
| IB/0028/G          | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation | 17/10/2014 | 31/03/2015 | SmPC, Labelling and PL |                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

|           | container or closure (immediate packaging) - Sterile medicinal products B.II.e.6.a - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that affects the product information                                                                                                               |            |            |                        |                                                                                                                                                                                                                                                                                                                                                       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0452   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                              | 28/07/2014 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                       |
| PSUV/0024 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                       | 10/07/2014 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                     |
| N/0026    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                             | 24/06/2014 | 31/03/2015 | PL                     |                                                                                                                                                                                                                                                                                                                                                       |
| II/0022   | Update of sections 4.5 and 4.8 of the SmPC following the review of clinical data supporting the safety profile of the product. The Package Leaflet is updated accordingly. Minor editorial changes have been introduced throughout the PI. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 25/04/2014 | 31/03/2015 | SmPC, Labelling and PL | In this variation the company proposed to update the product information of Nevanac to include newly identified safety information derived from analysis of available clinical data and post-marketing reports. As a result new side effects were included in the product information of Nevanac and the frequency of known side effects was updated. |
| PSUV/0023 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                       | 09/01/2014 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                     |
| N/0020    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                             | 14/08/2013 | 03/06/2014 | PL                     |                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| IG/0324   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                | 22/07/2013   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| X/0016    | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                                                                    | 21/02/2013   | 03/05/2013 | SmPC, Annex II, Labelling and PL | Please refer to the Assessment Report: Nevanac-H-818-X- 16-AR.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IG/0274   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                    | 19/03/2013   | 03/06/2014 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| R/0015    | Renewal of the marketing authorisation.                                                                                                                                                                       | 19/07/2012   | 24/09/2012 | SmPC, Annex II, Labelling and PL | The CHMP reviewed data on quality, safety and efficacy of Nevanac, including all variations introduced since the marketing authorisation was granted, and based on these data considered that the risk-benefit balance of Nevanac in the prevention and treatment of postoperative pain and inflammation associated with cataract surgery and for the reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients remains favourable. The CHMP recommended the renewal of the Marketing Authorisation with unlimited validity. Due to the limited data available for long-term use of Nevanac, the CHMP re-confirmed its previous decision that periodic safety update reports should be submitted every 6 months. |
| IG/0149/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.h - Changes to an existing pharmacovigilance | 06/03/2012   | 06/03/2012 | Annex II                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |             |                                                                  |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------|
| II/0007/G | This was an application for a group of variations. Update of sections 4.1, 4.2, 4.8 and 5.1 of the SmPC in order to reflect on the new approved indication 'reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients. Update of SmPC section 4.8 in order to include all available safety data and information on the new approved population, ie diabetic patients. Minor amendments to the SmPC were proposed by the MAH to reflect the SmPC guidelines of September, 2009. The sections 1, 3 and 4 of the Package Leaflet were amended accordingly Furthermore, the CHMP reviewed the data submitted by the Marketing Authorisation Holder, taking into account the provisions of Article 14(11) of Regulation (EC) No 726/2004 and does not consider by consensus, that the new therapeutic indication brings significant clinical benefit in comparison with existing therapies, as set out in Annex IV. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one | 17/11/2011 | 22/12/2011 | SmPC and PL | Please refer to the scientific discussion H-000818-II-0007- G-AR |

<div style=\"page-break-after: always\"></div>

|           | clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------|
| IG/0107/G | for a group of variations. C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the | 19/09/2011 | n/a        | This was an application DD |
| WS/0075   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To replace the current resin which is used for the closures for the drop-trainer packaging system, with two new resins. B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and medicinal products                                                                                                                                                                | 20/01/2011 | 20/01/2011 | biological/immunological   |

<div style=\"page-break-after: always\"></div>

| IG/0039   | C.I.9.i - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) to a DDPS following the assessment of the same DDPS in relation to another medicinal product of the same MAH                                                                                                                            | 17/01/2011   | n/a        | Annex II      |             |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------|-------------|
| II/0006   | To change the specification limit for colour of the finished products (eye drops suspension) from \"Light Yellow to Dark Yellow\" to \"Light Yellow to Light Orange\". B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change approved specifications limits range                             | 18/11/2010   | 17/01/2011 | SmPC and PL   | outside the |
| N/0005    | The Marketing Authorisation Holder (MAH) took the opportunity to update details of local representatives in Annex IIIB as well as some corrections of the Norwegian package leaflet in order to reflect the original English version. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 04/11/2010   | n/a        | PL            |             |
| IA/0004   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold                                                                                                                                                                                                                                                       | 29/09/2009   | n/a        |               |             |
| IA/0003   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold                                                                                                                                                                                                                                                       | 29/09/2009   | n/a        |               |             |
| N/0002    | Update of the list of the local representatives in section 6 of the Package Leaflet and translation of                                                                                                                                                                                                                                 | 14/01/2009   | n/a        | Labelling and |             |

<div style=\"page-break-after: always\"></div>

|         | INN into Bulgarian and Braille in the Bulgarian Labelling. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   |            |            | PL   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|
| II/0001 | Change(s) to the manufacturing process for the active substance                                                                                               | 25/09/2008 | 01/10/2008 |      |